BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28371279)

  • 1. EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10-ablation.
    You C; Zhao K; Dammann P; Keyvani K; Kreitschmann-Andermahr I; Sure U; Zhu Y
    J Cell Mol Med; 2017 Sep; 21(9):1848-1858. PubMed ID: 28371279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations.
    You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y
    J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
    Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
    Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.
    Djokovic D; Trindade A; Gigante J; Badenes M; Silva L; Liu R; Li X; Gong M; Krasnoperov V; Gill PS; Duarte A
    BMC Cancer; 2010 Nov; 10():641. PubMed ID: 21092311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1.
    Pedrosa AR; Trindade A; Fernandes AC; Carvalho C; Gigante J; Tavares AT; Diéguez-Hurtado R; Yagita H; Adams RH; Duarte A
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1134-46. PubMed ID: 25767274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor-A inhibits EphB4 and stimulates delta-like ligand 4 expression in adult endothelial cells.
    Yang C; Guo Y; Jadlowiec CC; Li X; Lv W; Model LS; Collins MJ; Kondo Y; Muto A; Shu C; Dardik A
    J Surg Res; 2013 Jul; 183(1):478-86. PubMed ID: 23394931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
    Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
    Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
    Benedito R; Rocha SF; Woeste M; Zamykal M; Radtke F; Casanovas O; Duarte A; Pytowski B; Adams RH
    Nature; 2012 Mar; 484(7392):110-4. PubMed ID: 22426001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis.
    Martiny-Baron G; Holzer P; Billy E; Schnell C; Brueggen J; Ferretti M; Schmiedeberg N; Wood JM; Furet P; Imbach P
    Angiogenesis; 2010 Sep; 13(3):259-67. PubMed ID: 20803239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic-induced anti-angiogenesis via miR-425-5p-regulated CCM3.
    Gao Y; Yin Y; Xing X; Zhao Z; Lu Y; Sun Y; Zhuang Z; Wang M; Ji W; He Y
    Toxicol Lett; 2016 Jul; 254():22-31. PubMed ID: 27132035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis.
    Brütsch R; Liebler SS; Wüstehube J; Bartol A; Herberich SE; Adam MG; Telzerow A; Augustin HG; Fischer A
    Circ Res; 2010 Sep; 107(5):592-601. PubMed ID: 20616313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin.
    Zhang J; Fukuhara S; Sako K; Takenouchi T; Kitani H; Kume T; Koh GY; Mochizuki N
    J Biol Chem; 2011 Mar; 286(10):8055-8066. PubMed ID: 21212269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of CCM3 promotes angiogenesis through activation and nuclear translocation of YAP/TAZ.
    Tang L; Zhou M; Xu Y; Peng B; Gao Y; Mo Y
    Biochem Biophys Res Commun; 2024 Mar; 701():149525. PubMed ID: 38320423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
    Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
    Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RHOQ is induced by DLL4 and regulates angiogenesis by determining the intracellular route of the Notch intracellular domain.
    Bridges E; Sheldon H; Kleibeuker E; Ramberger E; Zois C; Barnard A; Harjes U; Li JL; Masiero M; MacLaren R; Harris A
    Angiogenesis; 2020 Aug; 23(3):493-513. PubMed ID: 32506201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells.
    Harjes U; Bridges E; McIntyre A; Fielding BA; Harris AL
    J Biol Chem; 2014 Aug; 289(33):23168-23176. PubMed ID: 24939870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel peptide inhibitor of Dll4-Notch1 signalling and its pro-angiogenic functions.
    Zhu G; Lin Y; Ge T; Singh S; Liu H; Fan L; Wang S; Rhen J; Jiang D; Lyu Y; Yin Y; Li X; Benoit DSW; Li W; Xu Y; Pang J
    Br J Pharmacol; 2022 Apr; 179(8):1716-1731. PubMed ID: 34796471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium and Pericytes.
    Schulz GB; Wieland E; Wüstehube-Lausch J; Boulday G; Moll I; Tournier-Lasserve E; Fischer A
    Stroke; 2015 May; 46(5):1337-43. PubMed ID: 25791711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function.
    Williams CK; Li JL; Murga M; Harris AL; Tosato G
    Blood; 2006 Feb; 107(3):931-9. PubMed ID: 16219802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDCD10-Deficiency Promotes Malignant Behaviors and Tumor Growth via Triggering EphB4 Kinase Activity in Glioblastoma.
    Wan X; Saban DV; Kim SN; Weng Y; Dammann P; Keyvani K; Sure U; Zhu Y
    Front Oncol; 2020; 10():1377. PubMed ID: 32850441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.